Function analysis of Helicobacter pylori cag pathogenicity island
Function analysis of Helicobacter pylori cag pathogenicity island
批准号:
13670502
负责人:
AZUMA Takeshi
金额:
$2.56万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The diversity of the CagA phosphorylation site, which determines the binding affinity of CagA to SHP-2, is suspected to be an important variable in determining the clinical outcome of Helicobacter pylori infection. In this work, we investigated the diversity of CagA in isolates from two different areas in Japan (Fukui and Okinawa), where gastric cancer risk is different, and examined the relationship between the diversity and clinical outcome. A total of 158 clinical isolates (92 Fukui strains and 66 Okinawa strains) was subjected to sequence analysis of the cagA gene. We also examined the relationship between histological features and diversity of CagA. The CagA phosphorylation and the binding affinity of CagA to SHP-2 were also examined by in vitro infection using human gastric epithelial AGS cells. Almost all (98.9%) Fukui and 68.2% of Okinawa strains possessed East Asian CagA-positive strains. The grades of inflammation, activity of gastritis, and atrophy were significantly higher in gastritis patients infected with the East Asian CagA-positive strain than in gastritis patients infected with cagA-negative or Western CagA-positive strains. Furthermore, all gastric cancer strains were East Asian CagA-positive. Biochemically, the East Asian CagA protein exhibited stronger SHP-2 binding activity than the Western CagA did. These findings suggest that infection of East Asian CagA-positive H. pylori infection is substantially associated with atrophic gastritis and gastric cancer, and that persistent active inflammation induced by the East Asian CagA-positive strain, which possesses stronger SHP-2 binding activity than the Western type, may play a role in the pathogenesis of atrophic gastritis and gastric cancer.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Suto H, Azuma T, Ito S, Ohtani M, Dojo M, Ito Y, Kohli Y, Kuriyama M: "Helicobacter pylori infection induces hyperammonaemia in Mongolian gerbils with liver cirrhosis"Gut. 48. 605-608 (2001)
Suto H、Azuma T、Ito S、Ohtani M、Dojo M、Ito Y、Kohli Y、Kuriyama M:“幽门螺杆菌感染诱发肝硬化蒙古沙鼠高氨血症”Gut。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, Hatakeyama M: "SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein"Science. 295. 683-686 (2002)
Higashi H、Ttsutsumi R、Muto S、Sugiyama T、Azuma T、Asaka M、Hatakeyama M:“SHP-2 酪氨酸磷酸酶作为幽门螺杆菌 CagA 蛋白的细胞内靶标”科学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Higashi H, Tsutumi R, Muto S, Sugiyama T, Azuma T, et al.: "SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori, CagA protein"Science. 295. 683-686 (2002)
Higashi H、Tsutumi R、Muto S、Sugiyama T、Azuma T 等人:“SHP-2 酪氨酸磷酸酶作为幽门螺杆菌 CagA 蛋白的细胞内靶标”《科学》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Azuma T, Ito Y, Suto H, Ohtani M, Dojo M, Muramatsu A, Kuriyama M, Kato T: "The effect of Helicobacter pylori eradication therapy on dyspepsia symptoms in industrial workers in Japan"Aliment Pharmacol Ther. 15. 805-811 (2001)
Azuma T、Ito Y、Suto H、Ohtani M、Dojo M、Muramatsu A、Kuriyama M、Kato T:“幽门螺杆菌根除疗法对日本产业工人消化不良症状的影响”Aliment Pharmacol Ther。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Higashi H, Tsutumi R, Fujita A, Yamazaki S, Asaka M, Azuma J.: "Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites"Proc.Natl.Acad.Sci, USA. 99. 14428-14433 (2002)
Higashi H、Tsutumi R、Fujita A、Yamazaki S、Asaka M、Azuma J.:“幽门螺杆菌毒力因子 CagA 的生物活性由酪氨酸磷酸化位点的变化决定”Proc.Natl.Acad.Sci,美国。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 14 条
Medical application of atmospheric nonthermal plasmas.
-
批准号:26670382
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2014
-
负责人:AZUMA Takeshi
-
依托单位:
Management of Helicobacter infection and its related gastrointestinal diseases in Asia
-
批准号:25305027
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.23万
-
财政年份:2013
-
负责人:AZUMA Takeshi
-
依托单位:
Development of endoscopic treatment system using laser
-
批准号:24659366
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2012
-
负责人:AZUMA Takeshi
-
依托单位:
Development of MR endoscopy
-
批准号:22659146
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.07万
-
财政年份:2010
-
负责人:AZUMA Takeshi
-
依托单位:
Epidemiological study for association between Helicobacter infection and gastrointestinal diseases
-
批准号:22406026
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.48万
-
财政年份:2010
-
负责人:AZUMA Takeshi
-
依托单位:
Metabolome analysis in the gastric carcinogenesis induced by the cross-talk between Helicobacter pylori and host.
-
批准号:21390228
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.56万
-
财政年份:2009
-
负责人:AZUMA Takeshi
-
依托单位:
Epidemiological research for the relationship between Helicobacter pylori infection and gastrointestinal diseases in Asia
-
批准号:19406025
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.82万
-
财政年份:2007
-
负责人:AZUMA Takeshi
-
依托单位:
Development of order-made medicine for gastric cancer prevention
-
批准号:18390217
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.89万
-
财政年份:2006
-
负责人:AZUMA Takeshi
-
依托单位:
Analysis of risk factors for gastric cancer in order to construct tailor-made medicine for gastric cancer
-
批准号:15390231
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.94万
-
财政年份:2003
-
负责人:AZUMA Takeshi
-
依托单位:
Analysis of gastric epithelial lineage
-
批准号:11670488
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:1999
-
负责人:AZUMA Takeshi
-
依托单位:
Cathepsin E expression in pancreatic cancer
-
批准号:09670525
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:1997
-
负责人:AZUMA Takeshi
-
依托单位:
Cancer specific expression of Cathepsin E in pancreas
-
批准号:06670531
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.54万
-
财政年份:1994
-
负责人:AZUMA Takeshi
-
依托单位:
Rapid diagnostic test for Helicobacter pylori using endoscopic urease probe
-
批准号:06557039
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$5.63万
-
财政年份:1994
-
负责人:AZUMA Takeshi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于ZDHHC5蛋白调控NLRP3棕榈酰化修饰探讨健脾清热活血方修复CAG黏膜萎缩的机制研究
-
批准号:2026JJ80293
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:严巧锋
-
依托单位:
基于中医阴阳理论探讨香砂益胃汤通过IL-11/STAT3信号轴对CAG大鼠NF-κBp65活化水平及其介导炎性级联反应的影响
-
批准号:JCZRLH202600128
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
环黄芪醇(CAG)调控STC1结合N1ICD影响GLUT1的表达抑制角质形成细胞糖代谢失衡在银屑病发展中的作用
-
批准号:2026JJ81711
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:夏婕
-
依托单位:
基于类器官平台工具探究线粒体损伤在Hp感染相关萎缩性胃炎(CAG)发生及发展中的作用
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:徐善静
-
依托单位:
温针灸通过SOCS3负反馈调节JAK1/STAT3信号通路影响CAG小鼠胃黏膜炎症微环境的机制研究
-
批准号:2025JJ70548
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:冯芳
-
依托单位:
THAP11基因CAG重复RNA毒性介导脊髓小脑性共济失调51型的致病机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:谈丹丹
-
依托单位:
基于PINK1/Parkin通路探讨“通调五脏安脾胃”核心方调控线粒体
自噬治疗CAG的作用机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
CAG 重复扩增疾病中全局翻译抑制对神经元功能障碍的作用机制研究
-
批准号:24ZR1422700
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:卢俊梅
-
依托单位:
基于PKM2和MFN2互作调控线粒体动力学-糖酵解网络研究乐胃饮加味方干预CAG“炎-癌”转化的机制
-
批准号:LY23H270004
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:朱飞叶
-
依托单位:
基于BMP信号调控胃干细胞分化探讨健脾益气方修复CAG黏膜萎缩的作用机制
-
批准号:82305156
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王培
-
依托单位: